Author(s): Ayat Abbood, Zeina Malek, Yasser Al-Homsh, Nasser Thallaj


DOI: 10.52711/0974-360X.2022.00794   

Address: Ayat Abbood1*, Zeina Malek2, Yasser Al-Homsh3, Nasser Thallaj4
1Dept. of Medicinal Chemistry and Quality Control, Pharmacy Faculty, Tichreen University, Lattakia, Syria.
2Dept. of Life Sciences, Faculty of Dentistry, The Syrian Private University, Damascus, Syria.
3Dept. of Microbiology, Pharmacy Faculty, Al-Jazeera University, Damascus, Syria.
4Dept. of Medicinal Chemistry and Quality Control, Pharmacy Faculty, Al-Rachid University, Damascus, Syria.
*Corresponding Author

Published In:   Volume - 15,      Issue - 10,     Year - 2022

Oral and parenteral antibiotics as amoxicillin-clavulanate, nitrofurantoin, cephalosporins, ttrimethoprim-sulfamethoxazole or fluoroquinolones were recommended to treat urinary tract infections UTIs. Resistance of uropathogens to antibiotic poses a serious concern worldwide. Therefore, this study aimed to evaluate the resistance in vitro of urine bacteria isolated from adult male and female patients with UTI to common used antibiotics in Syria. A total of 111 urine samples were collected in the laboratory. Firstly, the bacteria caused UTIs was identified. Then, the susceptibility of isolated bacteria to 16 antibiotic were evaluated with disc-diffusion method. As expected, the prevalence of UTI was higher in females than in males. E. Coli revealed the highest prevalence (70%), while Klebsiella showed the next highest rate (33%). 99.1% of urine bacteria were resistant to at least 2 antibiotics (110samples/111 samples). A high rate of resistance (= 50%) among isolated urine bacteria was observed to 10 antibiotics. Only 6 antibiotics has a rate of resistance below 50%. Amikacin and imipenem were the most active antibiotic with 0% resistance followed by gentamycin (11%). High overall resistance rates above 90% was found to cefexime (92%), cephalexin (93%), and cephalothin (95%). Due to the high resistance rates and Multi-antibiotic resistance, antibiotics sales should be regulated and not sale without prescription in Syria.

Cite this article:
Ayat Abbood, Zeina Malek, Yasser Al-Homsh, Nasser Thallaj. In vitro Study for Antibiotic resistance of bacteria causing Urinary Tract Infection from Syrian adults. Research Journal of Pharmacy and Technology 2022; 15(10):4727-2. doi: 10.52711/0974-360X.2022.00794

Ayat Abbood, Zeina Malek, Yasser Al-Homsh, Nasser Thallaj. In vitro Study for Antibiotic resistance of bacteria causing Urinary Tract Infection from Syrian adults. Research Journal of Pharmacy and Technology 2022; 15(10):4727-2. doi: 10.52711/0974-360X.2022.00794   Available on:

1.    Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, Williamson DA, Paterson DL. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12(10):570-84. doi: 10.1038/nrurol.2015.199. Epub 2015 Sep 1. PMID: 26334085.
2.    Hrbacek J, Cermak P, Zachoval R. Current Antibiotic Resistance Trends of Uropathogens in Central Europe: Survey from a Tertiary Hospital Urology Department 2011-2019. Antibiotics, 2020 22;9(9):630. doi: 10.3390/antibiotics9090630. PMID: 32971752; PMCID: PMC7559630.
3.    Sihra N, Goodman A, Zakri R, Sahai A, Malde S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018;15(12):750-776. doi: 10.1038/s41585-018-0106-x. PMID: 30361493.
4.    Vasudevan R. Urinary tract infection: an overview of the infection and the associated risk factors. J Microbiol Exp. 2014;1(2):42-54. DOI: 10.15406/jmen.2014.01.00008
5.    American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008 Mar;111(3):785-94. doi: 10.1097/AOG.0b013e318169f6ef. PMID: 18310389.
6.    Ashish Vyas, Karamjeet Singh, Gaurav Kumar. Prevalence and drug resistance among bacteria of urinary tract infections in females in Punjab, India. Research J. Pharm. and Tech. 2017; 10(2): 575-578. doi: 10.5958/0974-360X.2017.00114.7.
7.    Rodriguez-Mañas L, Urinary tract infections in the elderly: a review of disease characteristics and current treatment options, Drugs Context, 2020;9:2020-4-13. doi:10.7573/dic.2020-4-13
8.    Rowe TA, Juthani-Mehta M, Urinary tract infection in older adults, Aging health, 2013;9(5):10.2217/ahe.13.38. doi:10.2217/ahe.13.38.
9.    Guglietta A, Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis, Future Microbiol., 2017;12:239-246. doi: 10.2217/fmb-2016-0145.
10.    Foxman B, Brown P, Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs, Infect Dis Clin North Am., 2003;17(2):227-41. doi: 10.1016/s0891-5520(03)00005-9. PMID: 12848468.
11.    Fakhria JM, Salma KJ, Haydaite A, Prevalence and associated factors of Urinary Tract Infection among female students in University of Babylon, Iraq, Research J. Pharm. and Tech., 2017; 10(6): 1976-1982. doi: 10.5958/0974-360X.2017.00346.8
12.    Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018 Jul;219(1):40-51. doi: 10.1016/j.ajog.2017.12.231. Epub 2018 Jan 2. PMID: 29305250.
13.    Critchley IA, Cotroneo N, Pucci MJ, Mendes R. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS One. 2019 Dec 10;14(12):e0220265. doi: 10.1371/journal.pone.0220265. PMID: 31821338; PMCID: PMC6903708.
14.    Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2005;49(5):2137-2139. doi:10.1128/AAC.49.5.2137-2139.2005
15.    Morosini MI, García-Castillo M, Coque TM, et al. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother. 2006;50(8):2695-2699. doi:10.1128/AAC.00155-06
16.    Astal Z, Sharif FA, Abdallah SA, Fahd MI. Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in the Gaza Strip. J Chemother. 2002;14(6):637-8. doi: 10.1179/joc.2002.14.6.637. PMID: 12583559.
17.    lores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. doi: 10.1038/nrmicro3432. Epub 2015 Apr 8. PMID: 25853778; PMCID: PMC4457377.
18.    Can F, Kurt-Azap Ö, İspir P, Nurtop E, Seref C, Loçlar İ, Aktaş ON, Orhan YC, Ergonul O. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli. J Glob Antimicrob Resist. 2016;4:49-52. doi: 10.1016/j.jgar.2015.10.006. Epub 2015 Nov 14. PMID: 27436393.
19.    Samir Issa Bloukh, Nageeb A. Hassan, Rand S. AlAni, Sabrina Ait Gacem, Urinary Tract Infection and Antibiotic Resistance among Pregnant and Non-pregnant females in UAE, Research J. Pharm. and Tech. 2021; 14(1):461-465. doi: 10.5958/0974-360X.2021.00084.6.
20.    Nanda Anima, Dhamodharan S, Nayak BK, Antibiotic Resistance Pattern Exhibited by Esbl (Extended Spectrum β-Lactamases) in Multidrug Resistant Strains, Escherichia coli, Research J. Pharm. and Tech 2017; 10(11): 3705-3708. doi: 10.5958/0974-360X.2017.00672.2
21.    Sreeja MK, Gowrishankar NL, Adisha. S, Divya. KC, Antibiotic Resistance-Reasons and the Most Common Resistant Pathogens – A Review, Research J. Pharm. and Tech., 2017; 10(6): 1886-1890. doi: 10.5958/0974-360X.2017.00331.6.
22.    Sangeetha N, Guidelines for Antibiotic Therapy of Urinary Tract Infection in Acute Pyelonephritis, Bacteriuria in Adolescents. Asian J. Pharm. Res., 2018; 8(2): 83-86. doi: 10.5958/2231-5691.2018.00014.X.
23.    Joshi Y, Gurung P, Jain S, Evaluation and Assessment of Drug Utilization in Patients of Urinary Tract Infections, Asian J. Pharm. Res., 2018; 8(3): 167-169. doi: 10.5958/2231-5691.2018.00029.1.
24.    Rajesh KS, Honey VS, Ullas Prakash D’souza, Ragava Sharma, Bharath Raj KC, Study of Antibiotic resistance pattern in uropathogens at a Tertiary Care Hospital. Research J. Pharm. and Tech., 2020; 13(3): 1253-1256. doi: 10.5958/0974-360X.2020.00231.0.
25.    Ahmed Abduljabbar Jaloob Aljanaby, Israa Abduljabbar Jaloob Aljanaby, Profile of Antimicrobial Resistance of Aerobic Pathogenic Bacteria isolated from Different Clinical Infections in Al-Kufa Central Hospital –Iraq During period from 2015 to 2017, Research J. Pharm. and Tech., 2017; 10(10):3264-3270. doi: 10.5958/0974-360X.2017.00579.0.
26.    Shireen Rana, Siddesh Basawaraj Sirwar, Vijayaraghavan. Prevalence and Antibiogram of Extended Spectrum beta- Lactamase Producing Klebsiella pneumoniae and Proteus mirabilis in UTI, Research J. Pharm. and Tech. 2015: 8(11): 1465-1468. doi: 10.5958/0974-360X.2015.00262.0.
27.    Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int. 2010;107(21):361-7. doi: 10.3238/arztebl.2010.0361. Epub 2010 May 28. PMID: 20539810; PMCID: PMC2883276.
28.    Gupta K, Sahm DF, Mayfield D, Stamm WE, Antimicrobial Resistance Among Uropathogens that Cause Community-Acquired Urinary Tract Infections in Women: A Nationwide Analysis, Clinical Infectious Diseases, 2001: 33(1): 89–94,
29.    B White B, Diagnosis and Treatment of Urinary Tract Infections in Children, Oregon Health and Science University, Portland, Oregon), Am Fam Physician. 2011 Feb 15;83(4):409-415.
30.    Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. Int J Health Sci (Qassim). 2019;13(2):48-55. PMID: 30983946; PMCID: PMC6436442.
31.    Alhambra A, Cuadros JA, Cacho J, Gómez-Garcés JL, Alós JI. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J Antimicrob Chemother. 2004 Jun;53(6):1090-4. doi: 10.1093/jac/dkh218. Epub 2004 Apr 29. PMID: 15117925.
32.    Sanchez GV, Babiker A, Master RN, Luu T, Mathur A, Bordon J. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother. 2016;60(5):2680-2683. doi:10.1128/AAC.02897-15
33.    Sharef SW, El-Naggari M, Al-Nabhani D, Al Sawai A, Al Muharrmi Z, Elnour I. Incidence of antibiotics resistance among uropathogens in Omani children presenting with a single episode of urinary tract infection. J Infect Public Health. 2015;8(5):458-65. doi: 10.1016/j.jiph.2015.01.005. Epub 2015 Mar 6. PMID: 25755002.
34.     Al-Faham Z, Habboub G, Takriti F. The sale of antibiotics without prescription in pharmacies in Damascus, Syria. J Infect Dev Ctries. 2011; 5(5):396-9. doi: 10.3855/jidc.1248. PMID: 21628818.
35.    Labban L, Thallaj N, Labban A, Assessing the Level of Awareness and Knowledge of COVID 19 Pandemic among Syrians, Archives of medicine, 2020 (12). DOI:10.36648/1989-5216.12.3.309.
36.    Al-Assil B, Mahfoud M, Hamzeh AR. First report on class 1 integrons and Trimethoprim-resistance genes from dfrA group in uropathogenic E. coli (UPEC) from the Aleppo area in Syria. Mob Genet Elements. 2013;3(3):e25204. doi: 10.4161/mge.25204. Epub 2013 Jun 3. PMID: 23956949; PMCID: PMC3742597.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available